J-Pharma Co., Ltd. (the "Company") discloses information in accordance with applicable laws and regulations, including the Financial Instruments and Exchange Act of Japan, as well as the "Rules Concerning the Timely Disclosure of Corporate Information" (hereinafter, the "Timely Disclosure Rules") set forth in the Tokyo Stock Exchange's Securities Listing Regulations.

In addition, even when information is not subject to statutory disclosure requirements or the Timely Disclosure Rules, the Company will proactively disclose information that it deems to have a significant impact on investors' investment decisions or that is considered useful in enhancing stakeholders' understanding of the Company, with due consideration to fairness and timeliness.

The Company appropriately protects personal information, customer information, confidential information, and other information whose disclosure may infringe upon the rights or interests of related parties if disclosed.

For disclosures required under applicable laws and regulations and the Timely Disclosure Rules, the Company releases information through TDnet (Timely Disclosure network), the Tokyo Stock Exchange's timely disclosure system, and EDINET (Electronic Disclosure for Investors' NETwork), Japan's electronic disclosure system for statutory filings such as securities reports, and subsequently posts such information on its corporate website.

For information not covered by these requirements, the Company will likewise endeavor to ensure that such information is communicated as fairly and widely as possible through publication on its website and other appropriate means.

The Company's plans, estimates, forecasts, projections, and other forward-looking statements are prepared based on information available at the time of disclosure and on certain assumptions that the Company considers reasonable.
These statements do not constitute guarantees or assurances regarding the achievement of future performance or the implementation of specific measures. Actual results may differ materially from those expressed or implied due to various uncertainties, including changes in the business environment, economic conditions, competitive circumstances, market demand, and amendments to applicable laws and regulations or other systems.

In order to prevent the leakage of financial results information and to ensure fairness, the Company observes a quiet period from the day following the end of each quarterly fiscal period until the announcement of financial results. During this period, the Company refrains from responding to inquiries or providing comments regarding financial results, except with respect to information that has already been publicly disclosed.

However, even during the quiet period, if an event occurs that falls under applicable laws, regulations, or the Timely Disclosure Rules, the Company will make timely and appropriate disclosures.

The Company strives to appropriately manage material non-public information and is committed to preventing insider trading through the establishment and operation of relevant internal rules, as well as through education and training for its directors, officers, and employees.